title: Influenza vaccination in patients with haematologic malignancies: analysis of practices in 200 patients in a single center.
abstract: OBJECTIVE
  Despite recent studies demonstrating immunogenicity and tolerance of influenza vaccine in patients with haematologic malignancies, practices are still heterogeneous. The aim of this study was to analyse practices and factors influencing vaccination in a single centre, in the light of recent literature data.
  
  
  METHODS
  Two hundred patients with haematologic malignancies were included and filled out a standardized questionnaire about influenza vaccination. They were observed prospectively during the epidemic season.
  
  
  RESULTS
  Our study revealed a poor uptake of influenza vaccination (vaccinal rate: 25.5%), in particular in patients younger than 65 y and those with no comorbidities. The main reasons for not being vaccinated were: the vaccination was not suggested to patients (53.7%), vaccination was contraindicated by doctors (24.2%), the patient refused it (21.5%). The main reasons for physicians for contraindicating the vaccine were: haematologic malignancy could be worsened by vaccination (33.3%), vaccination could generate illness or asthenia (27.8%), vaccination would not be efficient (16.7%), unknown (22.2%).
  
  
  CONCLUSIONS
  We believe that a better knowledge by physicians of tolerance and efficiency of the vaccine could enhance the vaccination coverage.
authors.affiliation: Centre Léon-Bérard, department of haematology, 28, rue Laennec, 69008 Lyon, France. flo.lachenal@free.fr
authors.forename: F
authors.initials: F
authors.lastname: Lachenal
authors.forename: C
authors.initials: C
authors.lastname: Sebban
authors.forename: M
authors.initials: M
authors.lastname: Duruisseaux
authors.forename: P
authors.initials: P
authors.lastname: Biron
authors.forename: J-Y
authors.initials: JY
authors.lastname: Blay
authors.forename: H
authors.initials: H
authors.lastname: Ghesquières
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D000075202:Contraindications; D005260:Female; D019337:Hematologic Neoplasms; D006801:Humans; D007252:Influenza Vaccines / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D016312:Treatment Refusal / Q000706:statistics & numerical data; D014611:Vaccination / Q000009:adverse effects / Q000706:statistics & numerical data*; D055815:Young Adult
chemical_list: D007252:Influenza Vaccines